ChartMill · Oct 6, 2026
Cannabis Stocks Aren’t a Recovery Trade: Narrow Leadership Splits Quality and Momentum
Cannabis stocks aren't one trade: weighted returns beat weak average breadth. JAZZ, CRON, ACB show quality, pure-play, and momentum split.
CR
NASDAQ · CRON
Cronos Group Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.29
Down-$0.05 (-1.37%)
Updated Oct 7, 2026, 10:02 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 59.51
- Dividend yield
- 0.00%
- 52-week range
- $2.38 – $3.61
- Volume
- 677.8K
- Avg. volume
- 1.99M
Price performance · CRON
CRON price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
CRON closed at $3.29 after 21 trading sessions, up 3.14% for the selected period.
- Last close
- $3.29
- Period change
- +3.14%
- Period low
- $3.14
- Period high
- $3.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $3.26 | $3.30 | $3.24 | $3.285 | 677.8K |
| Oct 5, 2026 | $3.23 | $3.3186 | $3.23 | $3.25 | 1.22M |
| Oct 2, 2026 | $3.25 | $3.28 | $3.19 | $3.225 | 1.24M |
| Oct 1, 2026 | $3.27 | $3.30 | $3.21 | $3.21 | 1.32M |
| Sep 30, 2026 | $3.37 | $3.38 | $3.25 | $3.30 | 1.82M |
| Sep 29, 2026 | $3.42 | $3.43 | $3.365 | $3.38 | 761.99K |
| Sep 28, 2026 | $3.31 | $3.455 | $3.29 | $3.41 | 1.13M |
| Sep 25, 2026 | $3.32 | $3.35 | $3.25 | $3.34 | 876.52K |
| Sep 24, 2026 | $3.40 | $3.4176 | $3.315 | $3.32 | 721.21K |
| Sep 23, 2026 | $3.455 | $3.455 | $3.385 | $3.40 | 512.82K |
| Sep 22, 2026 | $3.34 | $3.46 | $3.335 | $3.43 | 768.48K |
| Sep 21, 2026 | $3.35 | $3.39 | $3.31 | $3.33 | 472.13K |
| Sep 18, 2026 | $3.38 | $3.40 | $3.34 | $3.35 | 1.07M |
| Sep 17, 2026 | $3.33 | $3.41 | $3.31 | $3.37 | 748.09K |
| Sep 16, 2026 | $3.22 | $3.37 | $3.22 | $3.29 | 1.05M |
| Sep 15, 2026 | $3.22 | $3.22 | $3.16 | $3.20 | 591.46K |
| Sep 14, 2026 | $3.10 | $3.24 | $3.09 | $3.235 | 913.27K |
| Sep 11, 2026 | $3.18 | $3.185 | $3.11 | $3.14 | 710.83K |
| Sep 10, 2026 | $3.12 | $3.19 | $3.12 | $3.16 | 584.73K |
| Sep 9, 2026 | $3.18 | $3.195 | $3.13 | $3.155 | 605.77K |
| Sep 8, 2026 | $3.24 | $3.255 | $3.17 | $3.185 | 929.83K |
Latest CRON news
The latest Smart Investors Daily articles mentioning CRON.
Stock researchCompany · Overview
Company
Market Activity
Research & News
CRON research
Overview
Company profile and research snapshot.
Company profile
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $3.43
- Implied upside
- —
- Analysts
- 7
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 10, 2026 | CANACCORD GENUITY | Buy | — |
| Aug 7, 2026 | TD COWEN | Buy | — |
| Aug 6, 2026 | ROTH CAPITAL PARTNERS | Buy | — |
| May 12, 2026 | CANACCORD GENUITY | Buy | — |
| May 11, 2026 | CANACCORD GENUITY | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 5, 2026
Is Cronos Group (TSX:CRON) A Bargain Following Its Proposed $10 Million Settlement?
Cronos Group class action settlement proposal Cronos Group (TSX:CRON) has agreed to a proposed US$10,000,000 settlement covering securities class action claims tied to shareholders who acquired its U.S. listed stock between May 2019 and March 2020. The deal would resolve related U.S. and Ontario proceedings, with a November 19, 2026 court hearing set to decide on approval, dismissal of the actions, and the plan to distribute proceeds to eligible investors. Cronos Group enters this proposed...
Yahoo · Sep 28, 2026
Can Cronos turn production and brand power into a bigger cannabis comeback?
Investing.com -- Cronos Group’s manufacturing capacity, cannabis genetics and branded product portfolio are drawing renewed attention after the company showcased its operations at an investor day, prompting an analyst to raise its 12-month price target to C$5.50 from C$5.25.
Yahoo · Sep 28, 2026
Canadian Penny Stocks To Watch In September 2026
Global markets are adjusting to higher long term interest rates, with bond yields in countries like Australia moving toward levels not seen in years. That shift keeps investors focused on balance sheets and cash flow rather than hype. For Canadian penny stocks, it creates a window to look at lower priced businesses that still keep their finances in order. This article breaks down three such opportunities from our financially focused screener. The three penny stocks covered below are only a...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
